- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
is a division of
- Industry news
- Financings
News of the day
Forbes Medi-Tech Announces Completion of $3.8 Million Non-Dilutive Funding Transaction
May 12, 2008--Vancouver, Canada Forbes Medi-Tech Inc. (TSX:FMI, NASDAQ:FMTI) ("Forbes" or the "Company") today announced that, as part of its continuing reorganization plan, it has completed the previously announced transaction with a private investor (the "Investor") to reorganize Forbes Medi-Tech Operations Inc. ("FMTO"), a wholly owned subsidiary of Forbes. moreVIRTUALSCOPICS ANNOUNCES RESULTS OF ANNUAL STOCKHOLDERS' MEETING
ROCHESTER, NY - May 9, 2008 - VirtualScopics, Inc. (NasdaqCM: VSCP), a leading provider of advanced medical imaging for clinical trials, today announced the results of its annual stockholders' meeting held on May 8, 2008 in New York City. The stockholders elected all of the nominees put forward by the board of directors for a one year term: Colby Chandler, Robert Klimasewski, Sidney Knafel, Jeff Markin, Norman Mintz, Charles Phelps, Terence Walts, Dan Kerpelman and Mostafa Analoui. The... moreIssue of warrants in Pharmexa A/S
Hørsholm, May 9, 2008--The board of directors' decision to issue warrants is in accordance with the authorisation provided for in article 4.7 of the Company's articles of association following which warrants may be issued without any pre-emption right for the present shareholders of the Company. moreIndustry news search
Most Viewed News
Recent news
To keep up to date with news from this category use our
SomaLogic and Otsuka Enter into Research Collaboration Focusing On Diagnostic Products and Target Validation
BOULDER, CO- May 9, 2008 - SomaLogic, Inc. announced today that SomaLogic and Otsuka Pharmaceutical Co., Ltd. entered into a collaboration agreement to use SomaLogic's proprietary aptamer technology to discover and...
JAZZ PHARMACEUTICALS, INC. SECURES $75 MILLION COMMITTED EQUITY FINANCING FACILITY
PALO ALTO, Calif., May 8 -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that it has entered into a Committed Equity Financing Facility (CEFF) with Kingsbridge Capital Limited, a private investment group,...
LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES PRICING OF COMMON STOCK AND WARRANT UNIT OFFERING
SAN DIEGO, MAY 7, 2008 -- La Jolla Pharmaceutical Company (Nasdaq: LJPC) today announced the pricing of an underwritten public offering of 15,614,834 units, with each unit consisting of one share of common stock and a...
Phosphagenics Completes A$9.1 M Capital Raising
May 7, 2008 -- Phosphagenics Limited ("Phosphagenics") (ASX: POH, AIM: PSG, OTCQX: PPGNY) today announced that it has raised A$9.1 m via a placement of approximately 60.6 million fully paid ordinary shares to leading...
TopoTarget A/S issues 5,000,000 new shares to CuraGen Corporation
Copenhagen, Denmark - May 7, 2008 - TopoTarget A/S (OMX: TOPO) today announced that TopoTarget issues nominal DKK 5,000,000 shares to CuraGen Corporation in a direct placement as part consideration for the purchase by...
LAB Research Closes $21.1 Million Financing
LAVAL, Quebec, May 6, 2008 - LAB Research Inc. ("LAB Research" or the "Company"), a Canadian-based global non-clinical contract research organization, announces the execution of the financing agreement entered into on...
PDL Biopharma Announces Conversion Rate Adjustment for 2.00% Convertible Senior Notes Due February 15, 2012
REDWOOD CITY, CA, May 06, 2008 -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced an adjustment to the conversion rate for its 2.00% Convertible Senior Notes due February 15, 2012 (the "Notes"), as a result of...
MINRAD International, Inc. Announces $40.0 Million Private Placement
ORCHARD PARK, N.Y., May 5, 2008 -- MINRAD International, Inc. (Amex: BUF - News) today announced that it has entered into agreements to issue and sell an aggregate of $40.0 million of senior secured convertible notes...
Warnex Reports on its Debt Restructuring
Laval, QC, May 5, 2008 - On March 19, 2008, Warnex Inc. (TSX: WNX) ("Warnex") announced that it had entered into agreements in principle with the various holders of all of its outstanding debentures, aggregating...
Protox Announces Private Placement
Vancouver, British Columbia, May 5, 2008 - Protox Therapeutics Inc. (TSX:PRX) today announced that it intends to raise up to CDN $3 million through a private placement of common shares of the Company at a price of $0.70...
Kinetic Concepts, Inc. Closes Private Sale of Convertible Senior Notes Due 2015 Pursuant to Full Exercise of Over-Allotment Option
SAN ANTONIO-- May 2, 2008--Kinetic Concepts, Inc. (NYSE:KCI) today announced the closing of the private sale of an additional $90 million aggregate principal amount of its 3.25% convertible senior notes due 2015...
Share Buyback in H. Lundbeck A/S
May 02, 2008 -- Acting on its authorization to acquire up to 10% of its shares, Lundbeck's Supervisory Board has resolved to initiate a share buyback program. Under the program Lundbeck will buy own shares for an amount...
Aethlon Medical and Fusion Capital Execute Private Placement and Mutually Terminate March 2007 Common Stock Purchase Agreement
SAN DIEGO--May 2, 2008--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has entered into a private placement agreement with Fusion Capital Fund II, LLC for the sale of 1,000,000 shares of its common stock for...
Exactech Announces Sale of Common Stock Resulting in $20.2 Million in Gross Proceeds
GAINESVILLE, Fla. -May 01, 2008-- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that it has entered...
Esperion Therapeutics Completes $22.75 M Series A Financing
ANN ARBOR, Mich. & NEW YORK--May 01, 2008--Esperion Therapeutics, Inc. a biopharmaceutical company formed to focus on the discovery and development of compounds to treat cardiovascular and metabolic disease, today...
CoNCERT Pharmaceuticals Raises $37 Million in Series C Financing
Lexington, Mass - CoNCERT Pharmaceuticals, Inc., announced the closing of a $37 million Series C financing today. The Company intends to use the proceeds to further advance its deuterium chemistry platform and product...
Neurologix Completes Additional $5 Million Private Placement
FORT LEE, N.J., Apr 29, 2008 --Neurologix, Inc. (OTCBB:NRGX), a biotech company engaged in the research and development of innovative gene therapies for the brain and central nervous system, announced today that it...
Oxford Finance Corporation and Comerica Bank Provide $15 Million Loan Facility to VisualSonics Inc.
(ALEXANDRIA, VA) April 29, 2008 - Oxford Finance Corporation, the principal lender, and Comerica Bank, today announced they have finalized a $15 million senior secured loan agreement with VisualSonics Inc. Both...
Warner Chilcott Announces Settlement of Securities Litigation
ST. DAVID'S, Bermuda, April 29, 2008 -- Warner Chilcott Limited (Nasdaq: WCRX) today announced that it has reached an agreement in principle to settle a securities class action lawsuit pending in the United States...
Newron acquisition of Hunter-Fleming
Milan, Italy - April 29, 2008 - Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, today announces that Newron and Hunter-Fleming Limited...
Omnicell Announces Common Stock Repurchase Program
MOUNTAIN VIEW, Calif. - April 28, 2008 - Omnicell, Inc. (NASDAQ: OMCL), a leading provider of system solutions to acute healthcare facilities, announced today that its Board of Directors has approved the repurchase of...
Sciele Pharma, Inc. Adopts $100 Million Share Repurchase Program
ATLANTA--April 28, 2008--Sciele Pharma, Inc. (NASDAQ:SCRX), a specialty pharmaceutical company, today announced that its Board of Directors has adopted a new share repurchase program, authorizing the repurchase of up to...
AkzoNobel Share Buyback Program
Amsterdam, the Netherlands, April 28, 2008 -- AkzoNobel (Euronext Amsterdam: AKZ) has announced that, in line with the launch of its EUR 1 billion share buyback program on March 17, 2008, the company has repurchased...
Novo Nordisk A/S - Share repurchase programme
April 28, 2008 -- On 31 January 2008 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no. 2273/2003 of 22 December 2003, also referred to as...
MEDIS TECHNOLOGIES LTD. SECURES $60 MILLION COMMITTED EQUITY FINANCING FACILITY
April 28, 2008 -- NEW YORK- Medis Technologies Ltd. (NASDAQ:MDTL) announced today that it has obtained a committed equity line of credit facility under which it may sell up to $60 million of its registered common stock...
AspenBio Pharma Initiates Stock Buyback Plan
CASTLE ROCK, CO--April 25, 2008--AspenBio Pharma, Inc. (Nasdaq CM: APPY), an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for animals and humans, announced its board of...
Progenics Board Approves $15 Million Share Repurchase Program
TARRYTOWN, N.Y., April 24, 2008 -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced that its Board of Directors has approved a share repurchase program to acquire up to $15 million of its outstanding...
Ark Therapeutics Grp - AGM Results
London, UK, 24 April 2008: At the Annual General Meeting of Ark Therapeutics Group plc (LSE: AKT) held today all resolutions were duly passed with the exception of resolution 11. Resolution 11 was to empower the...
Aldagen Secures $18.4 Million in Financing
Durham, NC - April 23, 2008 - Aldagen, Inc. today announced it has raised $18.4 million in a private round of financing. The financing was obtained from existing investors, including Intersouth Partners,...
Argos Therapeutics Secures $35.2 Million Series C Financing
Durham, NC- April 23, 2008Argos Therapeutics today announced the closing of a $35.2 million tranched Series C financing. The financing was led by TVM Capital and included participation from new investors Mizuho Capital,...
Supernus Pharmaceuticals Completes $75 Million Non-Recourse Note Offering Secured by Oracea® and Sanctura® XR Royalties
Rockville, MD, April 23, 2008 -- Supernus Pharmaceuticals, Inc. today announced that it closed a private placement to institutional investors of $75 million in aggregate principal amount of non-convertible, non-recourse...
Cangene Corporation announces approval of normal course issuer bid
TORONTO and WINNIPEG, April 23 - Cangene Corporation ("Cangene" or the "Company") announced today that its previously announced normal course issuer bid (the "Bid") has been approved by the Toronto Stock Exchange (the...
New incentive plan in the Lundbeck Group
April 23, 2008 -- At a board meeting held on 22 April 2008, the Supervisory Board of H. Lundbeck A/S resolved, pursuant to the authorisation in article 4.3 of the company's articles of association, to issue warrants for...
EntreMed Will Not Seek Shareholder Approval for Reverse Stock Split at Annual Meeting
ROCKVILLE, Md., April 22, 2008 -- EntreMed, Inc.-- (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that the...
Innova invests in arGentis project
Tuesday, April 22, 2008 -Memphis-based drug startup arGentis Pharmaceuticals LLC is the first company to receive funding from Innova Inc., a new venture capital fund targeting small science and technology firms.
Cangene Corporation announces intention to commence normal course issuer bid
TORONTO and WINNIPEG, April 22 - Cangene Corporation ("Cangene" or the "Company") today announces that it has applied to the Toronto Stock Exchange (the "TSX") for approval to commence a normal course issuer bid (the...
BIOFISICA OBTAINS $2.3 MILLION IN FINANCING FROM INVESTORS
ATLANTA-- April 21, 2008 - Biofisica Inc., an Atlanta-based company specializing in wound care therapy, today announced that it has obtained a commitment of $2.3 million in financing from investors. The funding will...
Akzo Nobel Share Buyback Program (Week 16 of 2008)
Amsterdam, the Netherlands, April 21, 2008 -- Akzo Nobel (Euronext Amsterdam: AKZ) has announced that, in line with the launch of its EUR 1 billion share buyback program on March 17, 2008, the company has repurchased...
Vernalis and Paul Capital Healthcare Sign EUR18.4 Million Financing Agreement
NEW YORK, NY, and WINNERSH, U.K., April 21, 2008 -- Paul Capital Healthcare and Vernalis plc (LSE: VER) today announced that they have signed a financing agreement relating to frovatriptan, Vernalis' product for the...
Diamyd strengthens financial position and executes a fully subscribed direct placement
Stockholm, April 21, 2008--Diamyd MedicalAB (publ)(ticker DIAM B) has decided on and successfully executed a direct placement of in total 991,000 B shares. The shares have been placed with a limited group of...
Issue of new equity
April 21, 2008 - Tissue Science Laboratories announces that it has issued and allotted 85,000 new ordinary shares of 10 pence each in the Company, as a result of the exercise of options held under the Company share...
Novo Nordisk A/S - Share repurchase programme
April 21, 2008 -- On 31 January 2008 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as...
Share Purchase
South San Francisco, California, 21 April 2008 -- Napo Pharmaceuticals, Inc., (LSE: NAPL and NAPU), (the "Company") - The Company announces that on 21 April 2008, in relation to transactions of Directors and Persons...
CYBERONICS ANNOUNCES SETTLEMENT OF CONVERTIBLE NOTE LITIGATION
HOUSTON, Texas, April 21, 2008 -- Cyberonics, Inc. (NASDAQ:CYBX) today announced that it has settled the previously pending legal proceedings with note holders regarding an alleged default and acceleration of the...
IlluminOss Medical Completes $11 Million Series B Financing
East Providence, RI - April 18, 2008 - IlluminOss Medical Inc., a medical device company developing the revolutionary IlluminOss(TM) Photodynamic Bone Stabilization System (IBSS) for orthopedic surgery, today announced...
PLIVA Announces Share Capital Increase
April 18, 2008 - PLIVA's Share Capital shall be increased by HRK 194,570,800.00, from HRK 1,859,264,800.00 to HRK 2,053,835,600.00, through the issuance of 1,945,708 dematerialized ordinary registered shares, each in...
DuPont Purchases Equity Stake in Farms Technology
DES MOINES, Iowa, April 17, 2008 - DuPont today announced it has purchased an equity stake in Farms Technology as part of its strategy to create additional value for its customers and grain buyers. Specific details of...
BrainCells Inc. Expands Series B Financing to $50 Million
San Diego, CA, April 17, 2008 - BrainCells Inc. (BCI), a biopharmaceutical company utilizing its platform technology to identify and develop compounds that promote the growth of new neurons for the treatment of central...
Osteologix Completes $5.3 Million Private Placement Financing
SAN FRANCISCO, CA, April 17, 2008 - Osteologix, Inc. (OTCBB: OLGX) today confirmed that it has completed its previously announced private placement of common stock and warrants. The Company sold 4,030,304 shares of its...
EMD SERONO ANNOUNCES PLANNED INVESTMENT OF $50 MILLION IN RESEARCH CENTER IN MASSACHUSETTS
Rockland, Massachusetts, April 16, 2008 - Merck Serono and its US affiliate EMD Serono, Inc., both part of Merck KGaA, Darmstadt, Germany, announced today a planned expansion of EMD Serono's US presence with an...
Metabasis Therapeutics Raises Approximately $10 Million Through a Warrant Exchange and Concurrent Private Placement
SAN DIEGO-- April 16, 2008--Metabasis Therapeutics, Inc. (Nasdaq: MBRX) today announced that it had raised approximately $10 million through the successful completion of a warrant exchange and concurrent private...
Paratek Pharmaceuticals Completes $40 Million Private Placement to Finance Clinical Programs Including Oral Antibiotic to Combat MRSA and Other Infections
BOSTON, April 16, 2008 -- Paratek Pharmaceuticals, Inc. announced today that it has closed the second and final tranche of a $40 million private financing. As previously announced, Aisling Capital led the financing,...
Kinetic Concepts, Inc. to Offer Convertible Notes
SAN ANTONIO, Texas-- April 15, 2008--Kinetic Concepts, Inc. (NYSE: KCI) today announced that it is planning to offer $600 million aggregate principal amount of convertible senior notes due 2015, subject to market and...
Genentech Extends Stock Repurchase Program
South San Francisco, Calif -- April 15, 2008 -- Genentech, Inc. (NYSE: DNA) today announced that its Board of Directors has authorized the extension of its current stock repurchase program through June 30, 2009. The...
VisEn Medical Raises $5.0 Million in Expanded Series B Financing
Woburn, MA, April 18, 2008 - VisEn Medical, Inc., a leader in fluorescence in vivo imaging, today announced the expansion of its Series B financing. Merck Capital Ventures and Flagship Ventures co-led this $5.0 million...
Re: Equity Issue
April 14, 2008 -- Phynova Group plc (AIM: PYN), the developer of prescription pharmaceuticals derived from plants used in Chinese medicines, today announces that, further to the announcements issued by the Company on 27...
NIR DIAGNOSTICS COMPLETES PRIVATE PLACEMENT FINANCING
CAMPBELLVILLE, Canada, April 14, 2008 - NIR Diagnostics Inc. (the "Company") (TSX Venture: NID), an innovator in the development of handheld healthcare diagnostic devices, today announced that it has completed its...
Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
Redwood City, CA - April 14, 2008 --Codexis, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to the proposed initial public...
Akzo Nobel Share Buyback Program (Week 15 of 2008)
Amsterdam, the Netherlands, April 14, 2008 -- Akzo Nobel (Euronext Amsterdam: AKZ) has announced that, in line with the launch of its EUR 1 billion share buyback program on March 17, 2008, the company has repurchased...
Novo Nordisk A/S - Share repurchase programme
April 14, 2008 -- On 31 January 2008 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as...
Pathway Medical Technologies, Inc. Secures $24.5 Million Financing
Kirkland, WA, April 14, 2008--Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral arterial disease (PAD), announced today that it has successfully secured a $24.5 million Series...
FLUIDIGM FILES REGISTRATION STATEMENT FOR PROPOSED INITIAL PUBLIC OFFERING
Monday, April 14, 2008, South San Francisco, CA - Fluidigm Corporation announced today that it has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to the proposed initial...
NOVELOS THERAPEUTICS CLOSES $5.7 MILLION PRIVATE PLACEMENT
NEWTON, Mass., April 11, 2008 - Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that it closed its...
TYCO INTERNATIONAL ANNOUNCES PRELIMINARY AGREEMENT TO SETTLE BONDHOLDER LITIGATION
PEMBROKE, Bermuda--April 11, 2008 -- Tyco International Ltd. (NYSE: TYC, BSX: TYC) today announced that it has reached a preliminary agreement to settle the outstanding litigation related to its $3.7 billion of...
Oncothyreon announces effectiveness of shelf registration statement
BELLEVUE, WA, April 9, 2008 -- Oncothyreon Inc. (Nasdaq: ONTY) (TSX: ONY) announced today that the Securities and Exchange Commission has declared effective Oncothyreon's registration statement on Form S-3 (File #...
Potentia Pharmaceuticals Secures Additional $12 Million in Funding
April 9, 2008--Potentia Pharmaceuticals, Inc., a private development-stage biotechnology company, announced today that it has completed a $12 million round of financing. The funds will allow Potentia to complete Phase I...
Acquisition of shares for the William Ransom & Son plc Share Incentive Plan
April 08, 2008 - William Ransom & Son (the "Company") announces that WR Trustee Company Limited, a wholly owned subsidiary of the Company, has recently acquired a total of 113,507 shares in the Company on behalf of the...
Issue of new equity
April 08, 2008 - Tissue Science Laboratories announces that it has issued and allotted 1,823,600 new ordinary shares of 10 pence each in the Company, as a result of the exercise of options held under the Company share...
c-LEcta GmbH could complete another financing round among their partners.
April 08, 2008--c-LEcta GmbH could complete another financing round among their partners. Participating partners are the "High-Tech Gründerfonds", the "Sächsische Beteiligungsgesellschaft mbH" (SBG) and the "Warning...
Biofield Announces Reverse Split, New Head of Asian Operations, and New Office in Hong Kong to Oversee Asian Initiatives
April 07, 2008-The SEC has 10 days from the April 2 filing date to comment on the Information Statement. If there are no comments within that 10-day period, the Company will mail the Information Statement to...
AVANIR Announces Closing of $40 Million Registered Direct Offering
ALISO VIEJO, Calif., April 7, 2008 - AVANIR Pharmaceuticals (NASDAQ:AVNR) today announced that it has closed the previously reported sale of $40 million of common stock and warrants to a select group of institutional...
PLIVA Announces its Intention to Amend Bond Terms
April 07, 2008 -- On 12 May 2004, PLIVA d.d. (LSE: PLVD, ZSE: PLVA-R-A), ("PLIVA") issued nonmaterial registered bonds in the denomination of EUR 1.00, with an annual interest rate of 5.75% and a maturity date of 12 May...
Akzo Nobel Share Buyback Program (Week 14 of 2008)
Amsterdam, the Netherlands, April 7, 2008 -- Akzo Nobel (Euronext Amsterdam: AKZ) has announced that, in line with the launch of its EUR 1 billion share buyback program on March 17, 2008, the company has repurchased...
Quark Closes $27 Million Financing
Fremont, California, April 7, 2008 - Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company focused on discovering and developing novel RNA interference-based therapeutics, today announced the closing...
Plexus Completes Previously Announced Debt Offering $150 Million in Long-Term Debt and up to $200 Million in Revolving Credit
NEENAH, WI, April 4, 2008 -- Plexus Corp. (Nasdaq: PLXS) today announced that it has successfully arranged the debt facilities planned in connection with its financial recapitalization announced February 25, 2008.
Somanetics Announces Share Repurchase Program
TROY, Mich., April 3, 2008 -- Somanetics Corporation (Nasdaq: SMTS) announced today that its Board of Directors has authorized the Company to repurchase up to $15 million of its common shares. Purchases may be made from...
BDC Venture Capital and GO Capital invest in Alethia Biotherapeutics, a Montreal biotechnology firm
Montreal, April 3, 2008 - Alethia Biotherapeutics announces that it has secured C$2.4 M in financing from BDC Venture Capital and GO Capital Fund. This investment will allow Alethia to initiate the pre-clinical...
Alpha Pro Tech, Ltd. Announces $2 Million Stock Buy Back Program
NOGALES, ARIZONA - April 2, 2008 -- Alpha Pro Tech (AMEX: APT; CHX:APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building...
Generex Biotechnology Raises $20,650,000 Through Private Placement
WORCESTER, Mass., April 1, 2008 -- Generex Biotechnology Corporation (NasdaqCM:GNBT - News) announced today that it has signed definitive agreements for the issuance of 8% Secured Convertible Notes and Warrants in a...
Generex Biotechnology to Raise Nearly $21 Million by Issuing Notes and Warrants
Tuesday, April 01, 2008 -- WORCESTER, Mass. (AP) -- Generex Biotechnology Corp. said Tuesday it will issue 8 percent convertible notes and warrants to raise nearly $20.7 million in gross proceeds.
Codon Devices Secures $11 Million in Series B Financing
Cambridge, MA - March 31, 2008 - Codon Devices, the Constructive Biology(TM) Company, today announced it has secured an $11 million addition to its Series B financing, bringing the total of the Series B round to $31...
Grant Life Sciences (GLIF.OB) Receives a Waiver from N.I.R. Group That Allows Grant to Pursue Alternate Financing
March 31, 2008 -- LOS ANGELES-- Grant Life Sciences (OTC Bulletin Board: GLIF - News) announced today it has received a waiver from The N.I.R. Group, LLC ("N.I.R. Group"), a Roslyn, N.Y.-based hedge fund that allows...
QUOTIENT DIAGNOSTICS SECURES £1 MILLION FUNDING TO MOVE INTO PRODUCTION
March 30, 2008 - Quotient Diagnostics, developer of a new diabetes testing technology, has secured a further round of investment allowing it to take its Quo-Test system into production.
Oculus Innovative Sciences, Inc., Announces $13.9 Million Securities Offering
PETALUMA, Calif., March 28, 2008 -- Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), today announced an offering to sell securities to selected institutional investors for aggregate gross proceeds of $13,926,533. The...
NOVELOS THERAPEUTICS ANNOUNCES $5 MILLION PRIVATE PLACEMENT
NEWTON, Mass., March 27, 2008 - Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that it has entered into a...
AKELA PHARMA CLOSES CDN $10.35 MILLION FINANCING
Montreal, Canada, March 27, 2008 - Akela Pharma Inc. (TSX: "AKL"), a drug development company focused on developing therapies for the inhalation and pain markets, today announced that it has closed its previously...
CORCEPT THERAPEUTICS COMPLETES $25 MILLION PRIVATE EQUITY FINANCING AND SECURES COMMITTED EQUITY FINANCING FACILITY FOR UP TO $60 MILLION
Menlo Park, Calif., (March 26, 2008) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today confirmed that its previously announced private placement of Corcept common stock and warrants has been completed. Corcept...
Results of Placing and Open Offer
March 25, 2008 -- On 28 February 2008, Phytopharm plc (PYM: London Stock Exchange) ("Phytopharm" or the "Company") announced a Placing and Open Offer of 38,929,048 New Ordinary Shares at 22p per share to raise...
Materia / Cargill Venture Secures Independent Financing
PASADENA, CA -- (March 25, 2008) - Materia, Inc., a catalyst technology company and Caltech spin-off, announced today the creation and independent financing of a new company that builds on technology developed by...
AKELA PHARMA FILES FINAL SHORT FORM PROSPECTUS
Montreal, Canada, March 17, 2008 - Akela Pharma Inc. (TSX: "AKL"), a drug development company focused on developing therapies for the inhalation and pain markets, today announced that it has filed a final short form...
Nufarm completes $200 million placement
March 06, 2008 -- Nufarm Limited ("Nufarm") announced today that it has successfully completed the institutional placement to fund the acquisition of AH Marks Holdings Limited and proposed acquisition of Etigra LLC,...
Taligen Therapeutics Secures Series B Financing
Aurora, Colo., Feb. 1, 2008 - Taligen Therapeutics, Inc. today announced it anticipates receiving up to $65 million in a tranched Series B financing. The financing was led by Alta Partners and Clarus Ventures with...
MediGuide Signs Collaboration Agreement for Navigational Products with Medtronic
January,23,2008-The set of agreements includes co-development and an optional equity investment of Medtronic in MediGuide. The integration of the MediGuide MPS navigation technology into Medtronic tools is expected...
Ivivi Technologies, Inc. Completes $5.0 Million Private Placement of Common Stock
October 19, 2007 -- Ivivi Technologies, Inc. (AMEX:II), a leader in non-invasive, electrotherapeutic technologies, today announced that it has completed its previously announced private placement of its common stock...
Ivivi Technologies, Inc. Enters Into Definitive Purchase Agreement for Private Placement of Common Stock
October 16, 2007 -- Ivivi Technologies, Inc. (AMEX:II), a leader in non-invasive, electrotherapeutic technologies, today announced that it has entered into a definitive purchase agreement with an institutional investor,...
AKELA PHARMA INC. ANNOUNCES U.S. PUBLIC OFFERING AND PROPOSED LISTING
Montreal, Canada, October 15, 2007 - AKELA Pharma Inc., (TSX: AKL), a drug development company focused on developing therapies for the inhalation and pain markets, today announced that it is undertaking a public...
AKELA PHARMA INC. ANNOUNCES U.S. PUBLIC OFFERING AND PROPOSED LISTING
Montreal, Canada, October 15, 2007 - AKELA Pharma Inc., (TSX: AKL), a drug development company focused on developing therapies for the inhalation and pain markets, today announced that it is undertaking a public...
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us